Use of the live attenuated Japanese Encephalitis vaccine SA 14–14–2 in children: A review of safety and tolerability studies

References

• World Health Organization. Japanese Encephalitis Vaccines: WHO position paper - February 2015 . Weekly epidemiological record: Relevé épidémiologique hebdomadaire. World Health Organization; 2015; 69-88. Weekly epidemiological record Report No.: 9, 90. http://www.who.int/wer/2015/wer9009.pdf
   Google Scholar
• Campbell GL , Hills SL , Fischer M , Jacobson JA , Hoke CH , Hombach JM , Marfin AA , Solomon T , Tsai TF , Tsu VD. Estimated global incidence of Japanese encephalitis: a systematic review. Bulletin World Health Organization. 2011;89(10):766-74. doi:10.2471/BLT.10.085233
   PubMed Web of Science ®Google Scholar
• Halstead SB , Thomas SJ . Japanese encephalitis: new options for active immunization. Clin Infect Dis. 2010;50(8):1155-64. doi:10.1086/651271. PMID:20218889
   PubMed Web of Science ®Google Scholar
• Solomon T . Flavivirus encephalitis. N Eng J Med. 2004;351(4):370-8. doi:10.1056/NEJMra030476
   PubMed Web of Science ®Google Scholar
• Fischer M , Hills S , Staples E , Johnson B , Yaich M , Solomon T . Japanese encephalitis prevention and control: advances, challenges, and new initiatives. 2008 [accessed 2016 Mar 15 ]. http://www.asmscience.org/content/book/10.1128/9781555815592.ch06
   Google Scholar
• SAGE Working Group on Japanese encephalitis vaccine . Background Paper on Japanese Encephalitis Vaccines. Geneva, Switzerland : World Health Organization; 2014:1-74. http://www.who.int/immunization/sage/meetings/2014/october/1_JE_Vaccine_Background_Paper.pdf
   Google Scholar
• Zanin MP , Webster DE , Martin JL , Wesselingh SL . Japanese encephalitis vaccines: moving away from the mouse brain. Expert Rev Vaccines. 2003;2(3):407-16. doi:10.1586/14760584.2.3.407. PMID:12903806
   PubMedGoogle Scholar
• Gatchalian S , Yao Y , Zhou B , Zhang L , Yoksan S , Kelly K , Neuzil KM , Yaïch M , Jacobson J . Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants. Vaccine. 2008;26(18):2234-41. doi:10.1016/j.vaccine.2008.02.042. PMID:18394765
   PubMed Web of Science ®Google Scholar
• World Health Organization . Japanese encephalitis vaccines. Wkly Epidemiol Rec. 2006;81(34/35):331-40. PMID:16933380
   PubMedGoogle Scholar
• World Health Organization . Global Advisory Committee on Vaccine Safety, 9–10 June 2005. Weekly Epidemiol Rec. 2005;80(28):242-7
   PubMedGoogle Scholar
• Konishi E , Kitai Y , Tabei Y , Nishimura K , Harada S . Natural Japanese encephalitis virus infection among humans in west and east Japan shows the need to continue a vaccination program. Vaccine. 2010;28(14):2664-70. doi:10.1016/j.vaccine.2010.01.008. PMID:20080072
   PubMed Web of Science ®Google Scholar
• World Health Organization . Summary of Key Points - WHO Position Paper on Vaccines against Japanese Encephalitis (JE) February 2015. 2015 [accessed 2016 Mar 28 ]. http://www.who.int/immunization/policy/position_papers/pp_je_feb2015_presentation.pdf?ua=1
   Google Scholar
• Yu Y . Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine. 2010;28(21):3635-41. doi:10.1016/j.vaccine.2010.02.105. PMID:20226891
   PubMed Web of Science ®Google Scholar
• Desai K , Coudeville L , Bailleux F . Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine. Vaccine. 2012;30(15):2510-5. doi:10.1016/j.vaccine.2012.02.005. PMID:22342547
   PubMed Web of Science ®Google Scholar
• World Health Organization . WHO | Japanese encephalitis. WHO. 2015 Dec [accessed 2016 Mar 15 ]. http://www.who.int/mediacentre/factsheets/fs386/en/
   Google Scholar
• Tandan JB , Ohrr H , Sohn YM , Yoksan S , Ji M , Nam CM , Halstead SB . Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. [email protected]. Vaccine. 2007;25(27):5041-5. doi:10.1016/j.vaccine.2007.04.052. PMID:17521781
   PubMed Web of Science ®Google Scholar
• Ma WX , Yu YX , Wang SG , Zhou BL , Ma YH , Feng SY . A large-scale study on the safety and serological efficacy of live attenuated Japanese encephalitis vaccine. Chinese J Biol. 1993;6(4):1-5
   Google Scholar
• Xin YY , Ming ZG , Peng GY , Jian A , Min LH . Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Tropical Med Hygiene. 1988;39(2):214-7. doi:10.4269/ajtmh.1988.39.214
   PubMed Web of Science ®Google Scholar
• World Health Organization . Newly accessible Japanese encephalitis vaccine will make saving children easier in developing countries. Media Centre | WHO. 2013. [accessed 2016 Jun 11 ]. http://www.who.int/mediacentre/news/releases/2013/japanese_encephalitis_20131009/en/
   Google Scholar
• Gavi, the Vaccine Alliance . Japanese encephalitis vaccines: Frequently asked questions February 2014 page. 2014. http://www.gavi.org/Library/Documents/GAVI-documents/Guidelines-and-forms/Japanese-Encephalitis-vaccines-FAQ/
   Google Scholar
• Wang Y , Dong D , Cheng G , Zuo S , Liu D , Du X . Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China. Vaccine. 2014;32(44):5875-9. doi:10.1016/j.vaccine.2014.08.001. PMID:25173477
   PubMed Web of Science ®Google Scholar
• Glovax . Summary of Live attenuated SA14-14-2 Japanese Encephalitis vaccine post-marketing surveillance study in Korea (2002–2008). Seoul: Glovax Clinical Research and Regulation Regulatory Affairs; 2008
   Google Scholar
• Liu Y , Lin H , Zhu Q , Wu C , Zhao Z , Zheng H . Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005–2012. Vaccine. 2014;32(15):1768-73. doi:10.1016/j.vaccine.2013.11.107. PMID:24503272
   PubMed Web of Science ®Google Scholar
• Sohn YM , Park MS , Rho HO , Chandler LJ , Shope RE , Tsai TF . Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine. 1999;17(18):2259-64. doi:10.1016/S0264-410X(99)00006-7. PMID:10403593
   PubMed Web of Science ®Google Scholar
• Chotpitayasunondh T , Sohn YM , Yoksan S , Min J , Ohrr H . Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand. J Medical Association of Thailand = Chotmaihet Thangphaet. 2011;94:S195-203
   PubMedGoogle Scholar
• Ranganath BG , Hiremath SG . Adverse events following immunisation with SA 14-14-2 Japanese encephalitis vaccine in children of Kolar in Karnataka. J Indian Medical Association. 2012;110(1):10-12
   PubMedGoogle Scholar
• Choi UY , Lee SY , Kim KH , Kim DS , Choi KM , Cha SH , Kang JH . Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine? J Trop Pediatr 2013;59(5), 423–5; doi:10.1093/tropej/fmt043
   Google Scholar
• Kwon HJ , Lee SY , Kim KH , Kim DS , Cha SH , Jo DS , Kang JH . The immunogenicity and safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis vaccine given with a two-dose primary schedule in children. J Korean Med Sci. 2015;30(5):612-6. doi:10.3346/jkms.2015.30.5.612. PMID:25931793
   PubMed Web of Science ®Google Scholar
• Sanchayan K , Fernandopulle R , Amarasinghe A , Thiyahiny SN , Ranganathan SS . Safety of live attenuated Japanese encephalitis vaccine given at the age of 9 months in National Immunisation Programme of Sri Lanka. Ceylon Medical J. 2016;61(3):99-105. doi:10.4038/cmj.v61i3.8344
   PubMed Web of Science ®Google Scholar
• Wijesinghe PR , Abeysinghe MRN , Yoksan S , Yao Y , Zhou B , Zhang L , Fleming JA , Marfin AA , Victor JC . Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine. Vaccine. 2016;34(48):5923-8. doi:10.1016/j.vaccine.2016.10.028. PMID:27773472
   PubMed Web of Science ®Google Scholar
• Wijesinghe PR , Abeysinghe MN , Yoksan S , Yao Y , Zhou B , Zhang L , Yaich M , Neuzil KM , Victor JC . Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka. Vaccine. 2014;32(37):4751-7. doi:10.1016/j.vaccine.2014.06.036. PMID:24951871
   PubMed Web of Science ®Google Scholar
• Liu Z-L , Hennessy S , Strom BL , Tsai TF , Wan C-M , Tang S-C , Xiang C-F , Bilker WB , Pan X-P , Yao Y-J , et al. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J Infect Dis. 1997;176(5):1366-9. doi:10.1086/517323. PMID:9359740
   PubMed Web of Science ®Google Scholar
• Feroldi E , Pancharoen C , Kosalaraksa P , Chokephaibulkit K , Boaz M , Meric C , Hutagalung Y , Bouckenooghe A . Primary immunization of infants and Toddlers in Thailand with Japanese Encephalitis Chimeric virus vaccine in comparison with SA14-14-2 a randomized study of immunogenicity and safety. Pediatric Infect Dis J. 2014;33(6):643-9. doi:10.1097/INF.0000000000000276
   PubMed Web of Science ®Google Scholar
• Kim DS , Houillon G , Jang GC , Cha S-H , Choi S-H , Lee J , Kim HM , Kim JH , Kang JH , Kim J-H , et al. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea. Hum Vaccines Immunotherapeutics. 2014;10(9):2656-63. doi:10.4161/hv.29743
   PubMed Web of Science ®Google Scholar
• Zaman K , Naser AM , Power M , Yaich M , Zhang L , Ginsburg AS , Luby SP , Rahman M , Hills S , Bhardwaj M , et al. Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product. Vaccine. 2014;32(46):6061-6. doi:10.1016/j.vaccine.2014.09.012. PMID:25239483
   PubMed Web of Science ®Google Scholar
• Haldar D , Das S , Bisoi S , Basu M , Roy SK , Sinha A . Post-marketing Surveillance on Safety of Japanese Encephalitis Vaccine SA 14-14-2 in Burdwan District of West Bengal, India. 2014 [accessed 2016 Mar 28 ]. http://www.journalofcomprehensivehealth.co.in/archive/jan2014/PDF/Original%20Article1.pdf
   Google Scholar
• China Food and Drug Administration . National Guideline for Surveillance of adverse events following immunization. [accessed 2017 Jan 12 ]. http://www.sda.gov.cn/WS01/CL0056/57717.html
   Google Scholar
• Khan S , Kakati S , Dutta P , Chowdhury P , Borah J , Topno R , Jadhav S , Mohapatra P , Mahanta J , Gupte M . Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults. Indian J Medical Res. 2016;144(6):886. doi:10.4103/ijmr.IJMR_712_15
   PubMed Web of Science ®Google Scholar
• Ministry of Health & Indigenous Medicine . Change of the National Immunization Schedule: MMR, LJE vaccination. 2015 [accessed 2016 Sep 13 ]. http://www.epid.gov.lk/web/images/pdf/Circulars/MMR_LJEV/mmr_ljv_vaccination.pdf
   Google Scholar
• ClinicalTrials.gov . Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines. 2016 Sep 11 [accessed 2016 Sep 13 ]. https://clinicaltrials.gov/ct2/show/NCT02643433
   Google Scholar
• ClinicalTrials.gov . Immunogenicity and safety of Japanese encephalitis vaccine when given with measles-mumps-rubella vaccine. ClinicalTrials.gov. 2016 Sep 11 [accessed 2016 Sep 13 ]. https://clinicaltrials.gov/show/NCT02880865
   Google Scholar
• Li X , Ma S-J , Liu X , Jiang L-N , Zhou J-H , Xiong Y-Q , Ding H , Chen Q . Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic review. Hum Vaccines Immunotherapeutics. 2014;10(12):3579-93. doi:10.4161/21645515.2014.980197
   PubMed Web of Science ®Google Scholar
• Wang S-Y , Cheng X-H , Li J-X , Li X-Y , Zhu F-C , Liu P . Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis. Hum Vaccines Immunotherapeutics. 2015;11(6):1418-25. doi:10.1080/21645515.2015.1011996
   PubMed Web of Science ®Google Scholar
• Gao X , Li X , Li M , Fu S , Wang H , Lu Z , Cao Y , He Y , Zhu W , Zhang T , et al. Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011. PLoS Neglected Tropical Dis. 2014 [accessed 2016 Jun 11 ];8(8):e3015. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133196/. doi:10.1371/journal.pntd.0003015
   PubMed Web of Science ®Google Scholar
• Immunization Division, Department of Family Welfare, Ministry of Health and Family Welfare, Government of India . Operational Guide Japanese Encephalitis Vaccination in India. 2010 [accessed 2016 Mar 15 ]. http://www.iapcoi.com/hp/Dec%2025th/Guidelines-Japanese-Encephalitis,%20MoHFW,%20September%202010%5B2%5D.pdf
   Google Scholar
• SAS . Post Marketing Study of primary immunization in Burdwan, West Bengal and Bellary, Karnataka (2006–2007). New Delhi: SAS; 2008
   Google Scholar
• Upreti SR , Janusz KB , Schluter WW , Bichha RP , Shakya G , Biggerstaff BJ , Shrestha MM , Sedai TR , Fischer M , Gibbons RV , et al. Estimation of the Impact of a Japanese Encephalitis Immunization Program with Live, Attenuated SA 14-14-2 Vaccine in Nepal. Am J Tropical Med Hygiene. 2013;88(3):464-8. doi:10.4269/ajtmh.12-0196
   PubMed Web of Science ®Google Scholar
• VK R. AES/JE Surveillance - Directorate of National Vector Borne Disease Control Programme, Government of India Ministry of Health & Family Welfare. Presented at Bi-Regional Meeting on the Control of Japanese Encephalitis; 8 June 2009; Bangkok, Thailand.
   Google Scholar
• Gavi, the Vaccine Alliance . Japanese encephalitis vaccine support. [accessed 2016 Jun 11 ]. http://www.gavi.org/support/nvs/japanese-encephalitis/
   Google Scholar
• UNICEF - Media Centre . Nation-wide Japanese Encephalitis vaccination campaign launched in Cambodia and to be introduced into routine immunization schedule. UNICEF. 2016 [accessed 2017 Jan 11 ]. https://www.unicef.org/cambodia/12681_25295.html
   Google Scholar